review · 2025
Rilzabrutinib for the Treatment of Immune Thrombocytopenia
Advancements in the understanding of ITP pathogenesis have led to significant improvements in disease management through the use of both traditional immunosu...
8 citationsDOI: https://doi.org/10.1111/ejh.14425Open accessPDF reported by metadataFull text reported by metadata